Macula Densa SGLT1-NOS1-Tubuloglomerular Feedback Pathway, a New Mechanism for Glomerular Hyperfiltration During Hyperglycemia
BASIC RESEARCH www.jasn.org Macula Densa SGLT1-NOS1-Tubuloglomerular Feedback Pathway, a New Mechanism for Glomerular Hyperfiltration during Hyperglycemia Jie Zhang,1 Jin Wei,1 Shan Jiang,1 Lan Xu,2 Lei Wang,1 Feng Cheng,3 Jacentha Buggs,4 Hermann Koepsell,5 Volker Vallon,6 and Ruisheng Liu1 1Department of Molecular Pharmacology and Physiology, College of Medicine, 2Department of Biostatistics, College of Public Health, and 3Department of Pharmaceutical Science, College of Pharmacy, University of South Florida, Tampa, Florida; 4Advanced Organ Disease & Transplantation Institute, Tampa General Hospital, Tampa, Florida; 5Institute of Anatomy and Cell Biology, University of Würzburg, Würzburg, Germany; and 6Division of Nephrology and Hypertension, Department of Medicine, University of California, San Diego, La Jolla, California ABSTRACT Background Glomerular hyperfiltration is common in early diabetes and is considered a risk factor for later diabetic nephropathy. We propose that sodium-glucose cotransporter 1 (SGLT1) senses increases in luminal glucose at the macula densa, enhancing generation of neuronal nitric oxide synthase 1 (NOS1)– dependent nitric oxide (NO) in the macula densa and blunting the tubuloglomerular feedback (TGF) response, thereby promoting the rise in GFR. Methods We used microperfusion, micropuncture, and renal clearance of FITC–inulin to examine the effects of tubular glucose on NO generation at the macula densa, TGF, and GFR in wild-type and macula densa–specificNOS1knockoutmice. Results Acute intravenous injection of glucose induced hyperglycemia and glucosuria with increased GFR in mice. We found that tubular glucose blunts the TGF response in vivo and in vitro and stimulates NO generation at the macula densa. We also showed that SGLT1 is expressed at the macula densa; in the presence of tubular glucose, SGLT1 inhibits TGF and NO generation, but this action is blocked when the SGLT1 inhibitor KGA-2727 is present.
[Show full text]